Kitty Yale

Kitty Yale

Company: Akero Therapeutics

Job title: Chief Development Officer


Evolving Innovative Trial Design with Diverse Patient Populations to Optimize Clinical Development 11:00 am

Designing a robust development program to accelerate drug development F1, F2, F3, F4: navigating diverse patient populations in clinical studies to optimize treatment Evaluating clinical development of EFX in Phase IIb and histological outcomesRead more

day: Day 2 Stream 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.